Georgetown University Medical Center (GUMC) has named Mark Dybul, MD, as the inaugural faculty director of its new Center for Global Health and Quality.
Acute and chronic infections in a person’s upper gastrointestinal tract appear to be linked to Parkinson’s disease, say scientists at Georgetown University Medical Center and their collaborators at the National Institutes of Health and other institutions.
Rebecca Katz, PhD, MPH, co-director of the Center for Global Health Science and Security at Georgetown University Medical Center, will testify before a subcommittee of the U.S. Senate Committee on Foreign Relations examining the role of U.S. support for the World Health Organization.
In the first study of its kind, researchers say male mice have much greater brain distress in the week following a traumatic brain injury (TBI) than female mice, including skyrocketing inflammation and nerve cell death.
Georgetown University today announces it has exclusively licensed worldwide intellectual property (IP) rights to develop and commercialize uses of tyrosine kinase (TK) inhibitors for the treatment of neurodegenerative diseases to Axovant Sciences GmbH.
Georgetown University Medical Center autism specialists working with Latino families in Washington, DC, have developed an effective screening program that identifies Latino infants who may be at risk for autism spectrum disorder (ASD), allowing the opportunity for early intervention.
Of the 1,000 GI cancer patients seen at his clinic last year, nearly half were under age 50, says John L. Marshall, MD, director of the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center and chief of hematology and oncology at MedStar Georgetown University Hospital. Many are in their 20s and 30s; one was just 17.
A Georgetown physician-researcher has launched a first-of-its-kind study to test a medical care model that could change the way people with multiple sclerosis (MS) are treated.
How do factors such as race, culture, issues with accessing legal representation, and resiliency contribute to injustices for Native Americans? These are some of the issues to be discussed at a panel at Georgetown University titled "Justice in America for Native Americans."
“Urban Health: A Global Challenge" is a free satellite session on April 6, organized by Georgetown University, the International Society for Urban Health, and the New York Academy of Medicine. The session precedes the 2017 Annual CUGH Global Health Conference in Washington, DC.
The Open Philanthropy Project has awarded a $3.5 million grant to the Center for Global Health Science and Security at Georgetown University Medical Center to support research focused on improving U.S. and international biosecurity and pandemic preparedness policy.
Georgetown scientist and author Timothy Jorgensen looks back at the machine that changed the way we eat.
Georgetown researcher Peter Turkeltaub, MD, PhD, is awarded the Norman Geschwind Prize given annually by the American Academy of Neurology.
Georgetown University Medical Center today announces the launch of a phase II clinical trial to study the safety of the cancer drug nilotinib and its effects on clinical outcomes and biomarkers in people with Parkinson’s disease.
A recent survey suggests that many researchers have tried and failed to reproduce other scientists' experiments as well as their own. Georgetown University’s Rochelle Tractenberg, PhD, is on a mission to help change that by promoting ethical statistical practices. She’ll lead a panel discussion on the topic Sunday at the AAAS meeting in Boston.
In what is believed to be the first study of its kind, researchers at Georgetown University Medical Center’s Institute for Reproductive Health (IRH) announced today the launch of a year-long study to measure the efficacy of a new app, Dot™, for avoiding unintended pregnancy as compared to efficacy rates of other family planning methods.
Researchers who developed and tested a revolutionary laboratory technique that allows for the endless growth of normal and diseased cells in a laboratory are publicly sharing how the technique works.
An analysis of the New York State’s Medicaid expansion, which predated the 2010 Affordable Care Act, finds substantial decrease in uninsured rate but little change in racial disparities when it comes to access to cancer surgery – a proxy for complex cancer care.
Mindfulness meditation is an increasingly popular treatment for anxiety, but testing its effectiveness in a convincing way has been difficult. Now a rigorously designed, NIH-sponsored clinical trial has found objective physiological evidence that mindfulness meditation combats anxiety.
A clinical trial to examine the effect of nilotinib on clinical outcomes and biomarkers in people with mild to moderate Alzheimer’s disease has opened at Georgetown University Medical Center.
A synthesized steroid mirroring one naturally made by the dogfish shark prevents the buildup of a lethal protein implicated in some neurodegenerative diseases, reports an international research team studying an animal model of Parkinson’s disease. The clustering of this protein, alpha-synuclein (α-synuclein), is the hallmark of Parkinson’s and dementia with Lewy bodies, suggesting a new potential compound for therapeutic research.
At “Pandemic Preparedness in the Next US Presidential Administration,” a gathering of students and global health experts from academia, government and advocacy at Georgetown on January 10, Anthony S. Fauci, MD, and other global health leaders encouraged the incoming Trump administration to plan ahead.
As the United States prepares for new leadership, global health thought leaders will convene January 10 to discuss ways the Trump administration can contribute to pandemic preparedness, global health security, and domestic readiness and resilience.
Researchers have found that sunlight, through a mechanism separate than vitamin D production, energizes T cells that play a central role in human immunity. The findings suggest how the skin, the body’s largest organ, stays alert to the many microbes that can nest there.
A quest to understand if and how life can endure in extreme cold— on Earth and, perhaps one day, on Mars — is sending a team of Georgetown University researchers to Antarctica to search for, and then sequence, ancient bacteria.
Preparing dinner for a house packed with hungry family members on Thanksgiving Day can be stressful enough, but pepper it with conversation about politics and the 2016 election earlier this month, and the day could spoil easily.
Parents of children with autism under the age of six are invited to participate in a new study designed to evaluate “Sesame Street and Autism: See Amazing in All Children.”
The discovery of antibiotics remains one of the most important medical advances to date, but overuse and inappropriate use of antibiotics has led to many infections becoming resistant to treatment.
Georgetown University Medical Center (GUMC) will honor Roger I. Glass, MD, PhD, with the 2016 Cura Personalis Award at its Ninth Annual GUMC Convocation on Thursday, Nov. 17. Glass also will be the Convocation keynote speaker.
A new probe into why colorectal surgery patients end up back in the hospital after surgery suggests that it has less to do with the hospital or treatment received but rather more determined by patient factors such as race, income, and insurance status. The study underscores the vast challenge in leveling health disparities especially as some hospitals that serve these populations face disproportionately harsh penalties for outcomes directly impacted by such factors.
The Steering Committee of the National Action Partnership to Promote Safe Sleep (NAPPSS) is encouraged by the new American Academy of Pediatrics (AAP) “SIDS and Other Sleep-Related Infant Deaths: Updated 2016 Recommendations for a Safe Infant Sleeping Environment.”
The National Academy of Medicine has elected Andrew William Bazemore, MD, MPH, director, Robert Graham Center for Policy Studies in Family Medicine and Primary Care, and assistant professor of family medicine at Georgetown University School of Medicine, as a lifetime member.
In recent years, recommendations for breast feeding and safe sleep for infants have led to enormous challenges in moving from recommendations to action that benefit infant health. Now, a coalition funded by the U.S. Department of Health and Human Services aims to coalesce more than 60 groups to develop plans that move from “do and don’t” lists toward achieving the goals of breastfeeding and safe sleep advocates.
A protein produced by nerve cells appears to be elevated in the blood of those with an aggressive form of neuroblastoma. The finding could potentially lead to a prognostic test for the disease or be used to monitor its progress.
Yoshinori Ohsumi was awarded the 2016 Nobel Prize for Physiology or Medicine on Oct. 3 “for his discoveries of the mechanisms for autophagy”, which is how cells “recycle” their contents. A Georgetown University research explains how this work laid the groundwork for research he conducts in neurodegenerative diseases.
Today, the 2016 Nobel Prize in the category of medicine or physiology was awarded to Yoshinori Ohsumi “for his discoveries of mechanisms for autophagy,” a fundamental process for degrading and recycling cellular components. In describing autophagy, the prize committee says, “Intense research is now ongoing to develop drugs that can target autophagy in various diseases.” Some of that work is well underway at Georgetown University Medical Center.
Georgetown University Medical Center announces the launch of the Center for Global Health Science and Security to conduct research to help build sustainable capacities to prevent, detect, and respond to public health emergencies worldwide.
In this new era of legalized marijuana, far too little research has been conducted on the effect of cannabis on the development of human embryos, say researchers at Georgetown University Medical Center who scoured medical literature on the topic and found what they say is worrisome animal research.
Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use of nilotinib in a phase II clinical trial for patients with mild to moderate Alzheimer’s disease.
The prescription of testosterone supplementation for cardiovascular health, sexual function, physical function, mood, or cognitive function in men with “low T” is not supported by clinical trials data, conclude researchers who describe a review of more than 200 clinical trials published Sept. 21 in PLOS One.
Children differ substantially in their mathematical abilities. In fact, some children cannot routinely add or subtract, even after extensive schooling. This new paper proposes that math disability arises from abnormalities in brain areas supporting procedural memory. Procedural memory is a learning and memory system that is crucial for the automatization of non-conscious skills, such as driving or grammar.
The first known household survey examining the collateral harm to pregnancy services in areas affected by the West African Ebola epidemic suggests a significant slide backwards in child and maternal health. The study, conducted in Liberia, points to the deep disruptions caused by the Ebola epidemic — even in parts of the country with relatively limited transmission.
The Centers for Disease Control and Prevention has reported that the Zika virus has been transmitted by mosquito to a person in the continental United States, marking a moment in global health history so many predicted. Despite the advance warning of Zika’s approach, Georgetown experts in infectious disease, public health law and health systems readiness say the United States isn’t ready for a Zika outbreak.
Resveratrol, given to Alzheimer’s patients, appears to restore the integrity of the blood-brain barrier, reducing the ability of harmful immune molecules secreted by immune cells to infiltrate from the body into brain tissues, say researchers. The reduction in neuronal inflammation slowed the cognitive decline of patients, compared to a matching group of placebo-treated patients with the disorder.
An FDA approved drug to treat renal cell carcinoma appears to reduce levels of a toxic brain protein linked to dementia in Alzheimer’s and Parkinson’s diseases when given to animals. This finding is the latest from Georgetown University Medical Center’s Translational Neurotherapeutics Program (TNP) examining tyrosine kinase inhibitors in the treatment of neurodegenerative diseases.
The first case of Alzheimer’s disease diagnosed in an HIV-positive individual will be presented in a poster session at the Alzheimer’s Association International Conference 2016 in Toronto July 27. The finding in a 71-year-old man triggers a realization about HIV survivors now reaching the age when Alzheimer’s risk begins to escalate.
Eleven years ago in the New England Journal of Medicine, medical journalist Susan Okie, MD, first introduced readers to two U.S. Army veterans who suffered traumatic brain injuries in Iraq, and the challenges they faced in the recovery period after returning home. In the July 14 issue of the NEJM, Okie describes her follow-up interviews with the soldiers, and the slow journey to recovery that continues more than a decade later.
A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson’s disease or dementia with Lewy bodies.
You might not want to depend on your smartphone app alone to help you avoid or achieve pregnancy, say the authors of a new study. A review of nearly 100 fertility awareness apps finds that most don’t employ evidence-based methodology.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right